Ardent Health (ARDT) – Analysts’ Weekly Ratings Changes

Ardent Health (NYSE: ARDT) recently received a number of ratings updates from brokerages and research firms:

• 12/1/2025 – Ardent Health had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 11/24/2025 – Ardent Health had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $12.00. They now have a “neutral” rating on the stock.
• 11/23/2025 – Ardent Health was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/18/2025 – Ardent Health had its price target lowered by analysts at Mizuho from $20.00 to $13.00. They now have an “outperform” rating on the stock.
• 11/18/2025 – Ardent Health had its price target lowered by analysts at Guggenheim from $18.00 to $15.00. They now have a “buy” rating on the stock.
• 11/17/2025 – Ardent Health was downgraded by analysts at Weiss Ratings from a “hold (c-)” rating to a “sell (d+)” rating.
• 11/17/2025 – Ardent Health was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.
• 11/15/2025 – Ardent Health was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
• 11/14/2025 – Ardent Health was given a new $16.00 price target on by analysts at Leerink Partners.
• 11/14/2025 – Ardent Health had its price target lowered by analysts at Royal Bank Of Canada from $21.00 to $16.00. They now have an “outperform” rating on the stock.
• 11/14/2025 – Ardent Health had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now have a $12.00 price target on the stock, down previously from $22.00.
• 11/14/2025 – Ardent Health had its price target lowered by analysts at Truist Financial Corporation from $21.00 to $13.00. They now have a “buy” rating on the stock.
• 11/14/2025 – Ardent Health had its price target lowered by analysts at Stephens from $21.00 to $17.00. They now have an “overweight” rating on the stock.
• 11/13/2025 – Ardent Health had its price target lowered by analysts at Bank of America Corporation from $12.00 to $10.00. They now have an “underperform” rating on the stock.
• 10/24/2025 – Ardent Health was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
• 10/14/2025 – Ardent Health is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $19.00 price target on the stock.
• 10/14/2025 – Ardent Health is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $19.00 price target on the stock.
• 10/8/2025 – Ardent Health had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.